Familial hypercholesterolemia: a challenge of diagnosis and therapy

Area of Science:

• Cardiology
• Genetics
• Metabolic Disorders

Background:

• Familial hypercholesterolemia (FH) is a genetic disorder characterized by extremely high levels of low-density lipoprotein cholesterol (LDL-C).
• Elevated LDL-C accelerates atherosclerosis, significantly increasing the risk of premature cardiovascular death.
• The heterozygous form of FH is frequently undiagnosed, delaying necessary interventions.

Purpose of the Study:

• To highlight the critical importance of early detection of familial hypercholesterolemia.
• To emphasize the link between unrecognized FH and accelerated atherosclerosis.
• To underscore the potential for risk reduction through timely diagnosis and treatment.

Main Methods:

• Review of existing literature on FH pathophysiology and clinical outcomes.
• Analysis of epidemiological data regarding FH prevalence and cardiovascular risk.
• Discussion of diagnostic criteria and screening strategies for FH.

Main Results:

• Untreated FH leads to significantly elevated LDL-C levels.
• Accelerated atherosclerosis and early cardiovascular mortality are direct consequences of FH.
• Early identification of heterozygous FH enables proactive cardiovascular risk management.

Conclusions:

• Early detection of familial hypercholesterolemia is essential for preventing premature coronary heart disease.
• Recognizing and treating FH can mitigate the long-term risks of atherosclerosis.
• Timely intervention in FH patients is key to reducing cardiovascular mortality.